TARGETGENE BIOTECHNOLOGIES LTD
Oppenheimer 10 – Rehovot – 7670110
VAT: IL514820604
nan
Complicit EU Projects
TARGETGENE BIOTECHNOLOGIES LTD did not participate in Horizon 2020 (2014-2020).
Within the Horizon Europe (2021-2027) framework, TARGETGENE BIOTECHNOLOGIES LTD has received € 855,506.0 for its participation in a total of 1 project(s) with a total cost of € 2,733,931.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-01 | 101099867 | CAR T-REX | gene therapy · mutation · immunotherapy · genomes | 2027-03-31 | participant | € 855,506.25 | € 2,733,931 | 1 | 6 | CORDIS ↪ |
TARGETGENE BIOTECHNOLOGIES LTD did not participate in FP7 (2007-2013).